Weight Loss Drugs Alter More Than Just Appetite

The growing use of GLP-1 weight-loss medications, such as Mounjaro, is revealing unforeseen impacts beyond appetite suppression. These drugs, initially for type 2 diabetes, are now widely prescribed for weight management, with Australian prescriptions nearly tenfold since 2020 and US use quadrupling.

While physical side-effects like nausea are well-known, their effects on romantic relationships are less understood. Patients report changes in desire, sexual function, and emotional connection. Early research suggests GLP-1s may influence brain reward pathways, potentially affecting libido. Some studies show mixed results, with a significant percentage reporting changes in sexual desire, though distinguishing drug effects from other factors remains challenging.

Major weight loss itself, independent of medication, can alter relationships. A Swedish study found increased divorce rates among couples who underwent bariatric surgery. Similarly, GLP-1 users may experience shifts in self-confidence and social attention, prompting re-evaluation of existing partnerships. Therapists note that these medications can reveal underlying relationship issues rather than cause them.

Some individuals taking GLP-1s also report psychological challenges, including shame about their use, fearing judgment for lacking willpower. This internalized weight stigma can persist even after significant weight loss. For many, these medications may be a lifelong treatment, necessitating ongoing adaptation in personal and relational spheres.